4//SEC Filing
LIPOSCIENCE INC 4
Accession 0001127602-14-033298
CIK 0001168197operating
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 3:10 PM ET
Size
14.8 KB
Accession
0001127602-14-033298
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
Martindale Lucy G.
EVP and CFO
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.75/sh−22,940$63,085→ 0 totalExercise: $2.50Exp: 2019-02-06→ Common Stock (22,940 underlying) - Disposition to Issuer
Common Stock
2014-11-20$5.25/sh−107,881$566,375→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$1.37/sh−23,231$31,826→ 0 totalExercise: $3.88Exp: 2017-02-15→ Common Stock (23,231 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.75/sh−2,000$5,500→ 0 totalExercise: $2.50Exp: 2015-05-05→ Common Stock (2,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.79/sh−7,541$21,039→ 0 totalExercise: $2.46Exp: 2018-04-29→ Common Stock (7,541 underlying)
Footnotes (9)
- [F1]Disposed of pursuant to the Merger Agreement and includes 24,485 shares of the Issuer's common stock underlying restricted stock unit awards.
- [F2]The option was fully vested upon issuance on May 5, 2005.
- [F3]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $5,510.40, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F4]The option was fully vested upon issuance on February 15, 2007.
- [F5]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $31,912.42, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F6]The option was fully vested upon issuance on April 29, 2008.
- [F7]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $21,087.65, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F8]The option was fully vested upon issuance on February 6, 2009.
- [F9]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $63,204.29, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
Documents
Issuer
LIPOSCIENCE INC
CIK 0001168197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001168197
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 3:10 PM ET
- Size
- 14.8 KB